[PMID: 9413896] PubMed record related to this compound for laboratory literature review
10.1016/j.phrs.2005.12.005
The positive clinical data supporting GLP-1 receptor agonists for both glycemic control and weight loss has further enhanced their acceptance
Both disproportionality analyses confirmed this heightened risk: ROR analysis showed a statistically significant association (ROR = 1.81, 95% CI 1.622.03), while BCPNN yielded an information component of IC = 0.85 (IC025 = 0.69), both indicating substantially greater renal impairment risks in this older population treated with the combination therapy
It is bought online, meaning its purity, exact ingredients, and safe dosages are completely unknown
Agcakaya E, Mutlu HH, Erbakan A, Sargin M